All the news

People with non-alcoholic fatty liver disease (NAFLD) were found to have higher rates of cancer, with the greatest increase observed for gastrointestinal cancers, according to findings presented yesterday at the 2018 AASLD Liver ...

The US Food and Drug Administration last week granted accelerated approval for pembrolizumab (Keytruda), an immunotherapy drug known as a checkpoint inhibitor, for people with hepatocellular carcinoma (HCC). Over years or decades chronic hepatitis B ...

Co-infection with hepatitis C greatly increases the risk of pre-term delivery for pregnant women with HIV, Polish researchers reported last week at the International Congress on Drug Therapy in HIV Infection (HIV ...

Treatment for hepatitis C, especially if it leads to a cure, is associated with a reduced risk of cardiovascular events such as congestive heart failure, heart attacks and strokes, according to research presented ...

Registrations for liver transplants due to complications of hepatitis C infection in the United Kingdom fell sharply between 2013 and 2016, coinciding with the gradual increase in availability of direct-acting antiviral treatment, researchers ...

Only about a third of adolescents and young adults diagnosed with opioid use disorder in the United States are screened for hepatitis C virus (HCV) or HIV, even though injection drug use is ...

Lack of privacy, lack of peer support and lack of harm reduction are perceived as the biggest barriers to improving the uptake of direct-acting antiviral treatment for hepatitis C among prisoners, a qualitative ...

Hepatitis C co-infection can be eliminated in people living with HIV in the United Kingdom by 2021, the British HIV Association (BHIVA) said today. “The UK can be the first country to achieve ...

People with liver cirrhosis and their families need more information about their condition and prognosis and greater access to palliative care, a systematic review of studies on the needs of people with cirrhosis ...

Exclusive use of low dead-space syringes is associated with a lower prevalence of hepatitis C virus (HCV) in people who inject drugs, especially in people who began injecting drugs recently, a study ...